TNFRSF10D Antibody

Polyclonal Antibody

TNFRSF10D

CD 264 antibody, CD264 antibody, DcR 2 antibody, DcR2 antibody, Decoy receptor 2 antibody, Decoy with truncated death domain antibody, OTTHUMP00000123528 antibody, TNF receptor related receptor for TRAIL antibody, TNF related apoptosis inducing ligand receptor 4 antibody, TNF-related apoptosis-inducing ligand receptor 4 antibody, TNFRSF 10D antibody, TNFRSF10D antibody, TR10D_HUMAN antibody, TRAIL R4 antibody, TRAIL receptor 4 antibody, TRAIL receptor with a truncated death domain antibody, TRAIL-R4 antibody, TRAILR4 antibody, TRUNDD antibody, Tumor necrosis factor receptor superfamily member 10D antibody, Tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain antibody

Synthesized peptide derived from internal of human TNFRSF10D.

Receptor for the cytotoxic ligand TRAIL. Contains a truncated death domain and hence is not capable of inducing apoptosis but protects against TRAIL-mediated apoptosis. Reports are contradictory with regards to its ability to induce the NF-kappa-B pathway. According to it cannot but according to it can induce the NF-kappa-B pathway.

Marsters S.A., Curr. Biol. 7:1003-1006(1997).
Degli-Esposti M.A., Immunity 7:813-820(1997).
Pan G., FEBS Lett. 424:41-45(1998).

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Cell Biology

Synthesized peptide derived from internal of Human TNFRSF10D.